Cargando…

Beta-synemin expression in cardiotoxin-injected rat skeletal muscle

BACKGROUND: β-synemin was originally identified in humans as an α-dystrobrevin-binding protein through a yeast two-hybrid screen using an amino acid sequence derived from exons 1 through 16 of α-dystrobrevin, a region common to both α-dystrobrevin-1 and -2. α-Dystrobrevin-1 and -2 are both expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Yuji, Guyon, Jeffrey R, Ishii, Akiko, Hoshino, Sachiko, Ohkoshi, Norio, Tamaoka, Akira, Okamoto, Koichi, Kunkel, Louis M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1877804/
https://www.ncbi.nlm.nih.gov/pubmed/17493272
http://dx.doi.org/10.1186/1471-2474-8-40
_version_ 1782133563884306432
author Mizuno, Yuji
Guyon, Jeffrey R
Ishii, Akiko
Hoshino, Sachiko
Ohkoshi, Norio
Tamaoka, Akira
Okamoto, Koichi
Kunkel, Louis M
author_facet Mizuno, Yuji
Guyon, Jeffrey R
Ishii, Akiko
Hoshino, Sachiko
Ohkoshi, Norio
Tamaoka, Akira
Okamoto, Koichi
Kunkel, Louis M
author_sort Mizuno, Yuji
collection PubMed
description BACKGROUND: β-synemin was originally identified in humans as an α-dystrobrevin-binding protein through a yeast two-hybrid screen using an amino acid sequence derived from exons 1 through 16 of α-dystrobrevin, a region common to both α-dystrobrevin-1 and -2. α-Dystrobrevin-1 and -2 are both expressed in muscle and co-localization experiments have determined which isoform preferentially functions with β-synemin in vivo. The aim of our study is to show whether each α-dystrobrevin isoform has the same affinity for β-synemin or whether one of the isoforms preferentially functions with β-synemin in muscle. METHODS: The two α-dystrobrevin isoforms (-1 and -2) and β-synemin were localized in regenerating rat tibialis anterior muscle using immunoprecipitation, immunohistochemical and immunoblot analyses. Immunoprecipitation and co-localization studies for α-dystrobrevin and β-synemin were performed in regenerating muscle following cardiotoxin injection. Protein expression was then compared to that of developing rat muscle using immunoblot analysis. RESULTS: With an anti-α-dystrobrevin antibody, β-synemin co-immunoprecipitated with α-dystrobrevin whereas with an anti-β-synemin antibody, α-dystrobrevin-1 (rather than the -2 isoform) preferentially co-immunoprecipitated with β-synemin. Immunohistochemical experiments show that β-synemin and α-dystrobrevin co-localize in rat skeletal muscle. In regenerating muscle, β-synemin is first expressed at the sarcolemma and in the cytoplasm at day 5 following cardiotoxin injection. Similarly, β-synemin and α-dystrobrevin-1 are detected by immunoblot analysis as weak bands by day 7. In contrast, immunoblot analysis shows that α-dystrobrevin-2 is expressed as early as 1 day post-injection in regenerating muscle. These results are similar to that of developing muscle. For example, in embryonic rats, immunoblot analysis shows that β-synemin and α-dystrobevin-1 are weakly expressed in developing lower limb muscle at 5 days post-birth, while α-dystrobrevin-2 is detectable before birth in 20-day post-fertilization embryos. CONCLUSION: Our results clearly show that β-synemin expression correlates with that of α-dystrobrevin-1, suggesting that β-synemin preferentially functions with α-dystrobrevin-1 in vivo and that these proteins are likely to function coordinately to play a vital role in developing and regenerating muscle.
format Text
id pubmed-1877804
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18778042007-05-25 Beta-synemin expression in cardiotoxin-injected rat skeletal muscle Mizuno, Yuji Guyon, Jeffrey R Ishii, Akiko Hoshino, Sachiko Ohkoshi, Norio Tamaoka, Akira Okamoto, Koichi Kunkel, Louis M BMC Musculoskelet Disord Research Article BACKGROUND: β-synemin was originally identified in humans as an α-dystrobrevin-binding protein through a yeast two-hybrid screen using an amino acid sequence derived from exons 1 through 16 of α-dystrobrevin, a region common to both α-dystrobrevin-1 and -2. α-Dystrobrevin-1 and -2 are both expressed in muscle and co-localization experiments have determined which isoform preferentially functions with β-synemin in vivo. The aim of our study is to show whether each α-dystrobrevin isoform has the same affinity for β-synemin or whether one of the isoforms preferentially functions with β-synemin in muscle. METHODS: The two α-dystrobrevin isoforms (-1 and -2) and β-synemin were localized in regenerating rat tibialis anterior muscle using immunoprecipitation, immunohistochemical and immunoblot analyses. Immunoprecipitation and co-localization studies for α-dystrobrevin and β-synemin were performed in regenerating muscle following cardiotoxin injection. Protein expression was then compared to that of developing rat muscle using immunoblot analysis. RESULTS: With an anti-α-dystrobrevin antibody, β-synemin co-immunoprecipitated with α-dystrobrevin whereas with an anti-β-synemin antibody, α-dystrobrevin-1 (rather than the -2 isoform) preferentially co-immunoprecipitated with β-synemin. Immunohistochemical experiments show that β-synemin and α-dystrobrevin co-localize in rat skeletal muscle. In regenerating muscle, β-synemin is first expressed at the sarcolemma and in the cytoplasm at day 5 following cardiotoxin injection. Similarly, β-synemin and α-dystrobrevin-1 are detected by immunoblot analysis as weak bands by day 7. In contrast, immunoblot analysis shows that α-dystrobrevin-2 is expressed as early as 1 day post-injection in regenerating muscle. These results are similar to that of developing muscle. For example, in embryonic rats, immunoblot analysis shows that β-synemin and α-dystrobevin-1 are weakly expressed in developing lower limb muscle at 5 days post-birth, while α-dystrobrevin-2 is detectable before birth in 20-day post-fertilization embryos. CONCLUSION: Our results clearly show that β-synemin expression correlates with that of α-dystrobrevin-1, suggesting that β-synemin preferentially functions with α-dystrobrevin-1 in vivo and that these proteins are likely to function coordinately to play a vital role in developing and regenerating muscle. BioMed Central 2007-05-10 /pmc/articles/PMC1877804/ /pubmed/17493272 http://dx.doi.org/10.1186/1471-2474-8-40 Text en Copyright © 2007 Mizuno et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mizuno, Yuji
Guyon, Jeffrey R
Ishii, Akiko
Hoshino, Sachiko
Ohkoshi, Norio
Tamaoka, Akira
Okamoto, Koichi
Kunkel, Louis M
Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title_full Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title_fullStr Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title_full_unstemmed Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title_short Beta-synemin expression in cardiotoxin-injected rat skeletal muscle
title_sort beta-synemin expression in cardiotoxin-injected rat skeletal muscle
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1877804/
https://www.ncbi.nlm.nih.gov/pubmed/17493272
http://dx.doi.org/10.1186/1471-2474-8-40
work_keys_str_mv AT mizunoyuji betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT guyonjeffreyr betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT ishiiakiko betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT hoshinosachiko betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT ohkoshinorio betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT tamaokaakira betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT okamotokoichi betasyneminexpressionincardiotoxininjectedratskeletalmuscle
AT kunkellouism betasyneminexpressionincardiotoxininjectedratskeletalmuscle